Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
NPX887 for Cancer
Recruiting1 awardPhase 1
San Antonio, Texas
"This trial is testing a new antibody called NPX887 in cancer patients. The study wants to find out if NPX887 is safe and well-tolerated in patients with cancers that have a specific
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.